Diagnosis and treatment of rare mixed prostatic carcinoma.
- Author:
Lu YI
1
;
Luo-Yan YANG
;
Yin-Huai WANG
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; diagnosis; surgery; Carcinosarcoma; diagnosis; surgery; Humans; Male; Middle Aged; Prostatic Neoplasms; diagnosis; surgery; Retrospective Studies; Young Adult
- From: National Journal of Andrology 2009;15(8):727-729
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo discuss the diagnosis and treatment of rare mixed prostatic carcinoma.
METHODSWe retrospectively analyzed the clinical data of 6 cases of mixed prostatic tumor confirmed by surgery or transrectal ultrasound guided prostate biopsy, and reviewed the related literature.
RESULTSThree of the patients (2 with mixed small cell carcinoma and adenocarcinoma and 1 with adenosquamous carcinoma of the prostate) underwent palliative transurethral electrovaporization of the prostate (TUVP) and endocrine therapy, but all died within 7 - 10 months. The other 3 (2 with adenosquamous carcinoma and 1 with carcinosarcoma of the prostate) received cystoprostatectomy, urinary diversion, pelvic lymphadenectomy and radiation therapy, and survived for more than 12 months, with 2 of them still under the follow-up observation.
CONCLUSIONMixed prostatic carcinoma behaves aggressively with poor prognosis, of which the diagnosis relies on meticulous pathological examination and immunohistochemical techniques, and the most effective treatment is radical surgery.
